Kanname hoolt inimeste tervise eest igas maailma nurgas
Choose a category or subcategory
B. Braun Grupi uudised
Vaccination Supplies: Warning against Fraud Attempts with Supposed B. Braun Products
Once again, individuals are attempting to abuse the coronavirus situation and distribute products necessary for coronavirus vaccination, such as syringes or needles, using counterfeit B. Braun business documents.
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients.